Dexcom Inc. (NASDAQ: DXCM) is a medical device company that designs and develops continuous glucose monitoring systems targetting diabetes patients. The company’s products include Dexcom G6 and Dexcom Share. It markets its products directly to endocrinologists, physicians, and diabetes educators.
DXCM DexCom Inc NASDAQ
122.57 USD 2.50% +2.99
OPEN 120.00
PREV CLOSE 119.58
DAY RANGE 122.84 - 118.68
VOLUME 2.7M
AVG. VOLUME 3.1M
52 WEEK RANGE 126.44 - 67.11
Buy DXCM stocks now with Interactive Brokers – the most advanced investment platform
Valuations metrics
Market capitalization 47.5B
Enterprise value 45.9B
Trailing pe 167.9041
Forward pe 81.71333
Peg ratio 81.71333
Price to sales ttm 15.719617
Price to book mrq 21.27582
Enterprise to revenue 15.196
Enterprise to ebitda 84.834
Financials
Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin 0.09677
Operating margin 0.13137999
Return on assets ttm 0.04695
Return on equity ttm 0.13227999
Income statement
Revenue ttm 3B
Revenue per share ttm 7.773
Quarterly revenue growth 0.179
Gross profit ttm 1.9B
Ebitda 564M
Net income to common ttm 292.5M
Diluted eps ttm 0.73
Quarterly earnings growth yoy -0.501
Balance sheet
Total cash mrq 2.6B
Total cash per share mrq 6.622
Total debt mrq 2.1B
Total debt to equity mrq 95.96
Current ratio mrq 2.02
Book value per share mrq 5.761
Cash flow
Operating cash flow ttm 753.9M
Levered free cash flow ttm 429.1M
Stock statistics
Shares outstanding 387.6M
Float shares 384.5M
Avg 10 volume 3.1M
Avg 30 volume 2.6M
Shares short 14.5M
Short ratio 6.01
Short percent of shares outstanding 0.0422
Percent held by insiders 0.00408
Percent held by institutions 1.00063
Stock price summary
Fifty two week low 67.11
Fifty two week high 126.44
Fifty two week change 39.561
Beta 1.153061
Day 50 ma 118.0684
Day 200 ma 108.4773
Dividends and splits
Last split factor 4-for-1 split
Last split date 2022-06-13